Observational study / 2006
Lower A1 beta-casein intake at age 2 was linked to lower type 1 diabetes incidence in Iceland compared to Scandinavia.
Researchers compared the consumption of cow milk proteins A1 and B beta-casein among 2-year-olds and 11- to 14-year-olds in Iceland and Scandinavia (Norway, Denmark, Sweden, and Finland) and evaluated it against type 1 diabetes incidence (0-14 years). Among 2-year-olds, consumption differed significantly between Iceland and Scandinavia for A1 (p = 0.034) and the sum of A1 and B beta-casein (p = 0.021), and A1 consumption correlated with type 1 diabetes incidence across the countries (r = 0.9; p = 0.037). No significant difference in consumption of A1 or the sum of A1 and B beta-casein was observed for 11- to 14-year-olds.
Shows an association, not proof of cause and effect.
- Study type
- Ecological comparative study
- Who was studied
- Children (2-year-olds) and adolescents (11- to 14-year-olds) in Iceland and Scandinavia
- What was measured
- Consumption of A1 and B beta-casein and type 1 diabetes incidence
THE PAPER
Lower consumption of cow milk protein A1 beta-casein at 2 years of age, rather than consumption among 11- to 14-year-old adolescents, may explain the lower incidence of type 1 diabetes in Iceland than in Scandinavia.
Birgisdottir BE, Hill JP, Thorsson AV, Thorsdottir I. Ann Nutr Metab, 2006.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.